Cite

HARVARD Citation

    Ferris, R. et al. (2015). A Phase Ib study of neoadjuvant immune biomarker modulation with cetuximab and motolimod in head and neck cancer (HNC). Journal for immunotherapy of cancer. 3 (2), p. 1. [Online]. 
  
Back to record